http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2005017486-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ec836c8eb32531d51fbef9a920e35852
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_23b259446bacf1e5f6f16bc89d35c30a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e4ca3b82dfcf76ddbc137bc0f86b9d86
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-52
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-86
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-567
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-86
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-543
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N-
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-537
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-53
filingDate 2004-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ed1df34acf5fcc50f7f22135eb01efe4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03b17b297ec498eb1243ce6a8e541657
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8df4e15143da8e6958c034372e555807
publicationDate 2006-08-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2005017486-A3
titleOfInvention A global test of the hemostatic system
abstract This invention demonstrates the feasibility of producing an easy to use, marketable global test in the arena of clinical haemostasis testing that is sensitive to antithrombotic drugs, bleeding disorders and thrombotic pathologies. Use of this assay will provide insight into what predisposes an “apparently” healthy individual to thrombose, what effect does known risk factors (i.e. birth control/hormone replacement therapy) have on thrombin generation and whether certain individuals should be excluded from specific therapies because of an underlying genetic abnormality, among other things.
priorityDate 2003-06-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6645768-B1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005221414-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2003064414-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431577138
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID90470996
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP84122

Total number of triples: 29.